Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program

20Lighter2,200 enrolled

Overview

A retrospective review of body composition outcomes of participants of a comprehensive visceral-fat focused anti-obesity program. Data from approximately 2000-2500 participants are expected to be included in the study.

This is a retrospective, multi-center clinical study to evaluate the efficacy of the 20Lighter comprehensive anti-obesity program in reducing body composition measures including body weight, body fat, visceral adiposity, intracellular fluid, and other metrics of interest. Anecdotal evidence on reductions of prescription medication, chronic health issues, and improvements in quality of life will be gauged via review of patient assessment forms and surveys.

Study Type

OBSERVATIONAL

Enrollment

2,200

Conditions

Obesity Obesity, Morbid Obesity, Visceral Central Obesity Metabolic Disease Hypertension Dyslipidemias

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * BMI \>25 * ability to stand on platform for body composition analysis Exclusion Criteria: * Pregnant at time of enrollment * Breastfeeding at time of enrollment * Undergoing treatment for cancer at time of enrollment * History of major organ transplant with immunosuppressant medication * Over the 70 years of age with diagnosis of three cardiovascular comorbidities at time of enrollment * Adult with a vegetarian diet * Diagnosis of psychiatric conditions including: schizophrenia, bipolar disorder, manic depression

Outcomes

Primary Outcomes

Reduction of Visceral Adiposity

% reduction of visceral adiposity (as measured by visceral fat rating) measured via an FDA-cleared Class 2 medical device with Bioelectrical Impedance Analysis (BIA) via bipolar foot electrodes.